← Open Payments lookup

SIMON ORDONEZ: Open Payments

NPI 1891145884 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,649 in 111 payments from 18 companies in 2025. Trend: 2023 $1,825 · 2024 $1,125 · 2025 $2,649

Food & beverage: $2,649
CompanyPaymentsAmount
Axsome Therapeutics, Inc.9$456
Vanda Pharmaceuticals Inc.15$308
E.R. Squibb & Sons, L.L.C.5$281
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$242
Janssen Pharmaceuticals, Inc6$232
ABBVIE INC.20$173
Neurocrine BioSciences, Inc.6$172
Alkermes, Inc.6$153
Bausch Health US, LLC10$146
Corium, LLC7$135

Products named: Auvelity, FANAPT, COBENFY, CAPLYTA, VRAYLAR, INGREZZA, REXULTI, INVEGA SUSTENNA.

Industry payments across TX — which companies pay providers there.